PHILLIP SAMAYOA
Principal at Atlas Venture
FormerInvestor
Updated: ·
About
Phillip Samayoa is Principal at Atlas Venture.
Recent News & Mentions
Jan 29, 2026FundingIndigo - Series BJan 29, 2026FundingIndigo - Series BJan 1, 2025FundingIndigo - SeedAug 1, 2020FundingDyne Therapeutics - Series BJan 1, 2020FundingGeneration Bio - Series CApr 1, 2019FundingDyne Therapeutics - Series AOct 1, 2018FundingAxcella - Series EJan 1, 2018FundingGeneration Bio - Series AJan 1, 2017FundingTranslate Bio - Series CJul 1, 2015FundingTranslate Bio - Series B
Experience
Principal
Atlas VentureJan 2016 - Dec 2018
Co-Founder and Chief Strategy OfficerCurrent
Generation BioJan 2022 - Present
Co-Founder
Dyne TherapeuticsJan 2017 - Dec 2018
Principal, MRL Ventures
MerckJan 2016 - Dec 2016
Board Observer
Translate BioJan 2015 - Dec 2016
Co-Founder
Codiak BiosciencesJan 2014 - Dec 2015
Founding Team
IndigoJan 2014 - Dec 2014
Associate
Flagship PioneeringJan 2012 - Dec 2015
Product Strategy and Intellectual Property
Pronutria BiosciencesJan 2012 - Dec 2014
Product Strategy and Intellectual Property
AxcellaJan 2012 - Dec 2014
VentureLabs Entrepreneurial Fellow
Flagship VenturesJan 2012 - Dec 2012
Computational Systems Biology Intern
Bayer Technology ServicesJan 2009 - Dec 2009
Consulting Intern
Decision ResourcesJan 2008 - Dec 2008
Cancer Biochemistry Intern
Infinity PharmaceuticalsJan 2007 - Dec 2007
Frequently Asked Questions
Who is Phillip Samayoa?
Phillip Samayoa is Principal at Atlas Venture.